Merck & Co. signed a licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) that will allow more companies to manufacture generic versions of the company’s experimental oral antiviral Covid-19 treatment, the U.S. drugmaker and the organization announced on Oct. 27.
If you are not happy with the results below please do another search
50 search results for:
Novavax Inc. said on Oct. 27 the company had completed the real-time submission of an application for the authorization of the Covid-19 vaccine candidate NVX-CoV2373 in the United Kingdom.
The U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee recommended emergency use authorization (EUA) for the Pfizer-BioNTech vaccine for children 5 through 11 years of age, with 17 members voting yes and one abstention.
Raytheon Technologies’ top boss warned on Oct. 26 that the U.S. aerospace and defense firm will lose ‘several thousand’ employees who refused to take Covid-19 vaccines, as the company prepares to meet the Biden administration’s Dec. 8 deadline for immunization.
Cortexyme Inc. said on Oct. 26 the company’s experimental oral pill failed to meet the main goals of improving cognitive and functional abilities in patients with mild-to-moderate Alzheimer’s disease in a study.
With companies like GlaxoSmithKline and bluebird bio moving closer to splitting their businesses into multiple entities, Novartis is reviewing the Swiss drugmaker’s Sandoz division to determine the best moves going forward to maximize value for shareholders.
Scientists are scrambling to find the cause for the sudden spike in human cases of avian influenza A (H5N6) in China to 21 during year-to-date 2021, from only five in 2020, reports say.
Seattle-based Mozart Therapeutics closed on a $55 million Series A financing round, led by seed financier ARCH Venture Partners along with Sofinnova Partners. Additional investors were Eli Lilly and Company, MRL Ventures Fund, an early-stage fund run by Merck & Co., Leaps by Bayer, Altitude Life Science Ventures, and Alexandria Venture Investments.
The U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee is meeting Oct. 26 to discuss and recommend an emergency use authorization for the Pfizer-BioNTech vaccine for children 5 through 11 years of age.
Becton Dickinson and Co. has partnered with Amazon.com Inc. to begin shipment of a new at-home rapid Covid-19 test that can confirm results using an entirely automated smartphone app.